Maintenance of efficacy of lisdexamfetamine dimesylate in children and adolescents with attention-deficit/hyperactivity disorder: randomized-withdrawal study design

David R. Coghill; Tobias Banaschewski; Michel Lecendreux; Mats Johnson; Alessandro Zuddas; Colleen S. Anderson; Richard Civil; Matthew Dauphin; Nicholas Higgins; Andrew Lyne; Maria Gasior; Liza A. Squires

doi:10.1016/j.jaac.2014.01.017

Maintenance of efficacy of lisdexamfetamine dimesylate in children and adolescents with attention-deficit/hyperactivity disorder: randomized-withdrawal study design

David R. Coghill (Lead / Corresponding author)
, Tobias Banaschewski
, Michel Lecendreux
, Mats Johnson
, Alessandro Zuddas
, Colleen S. Anderson
, Richard Civil
, Matthew Dauphin
, Nicholas Higgins
, Andrew Lyne
, Maria Gasior
, Liza A. Squires

Research output: Contribution to journal › Article › peer-review

52 Citations (Scopus)

408 Downloads (Pure)

Abstract

In this phase 3 extension study, the long-term maintenance of efficacy of lisdexamfetamine dimesylate (LDX) in children and adolescents with attention-deficit/hyperactivity disorder (ADHD) was evaluated using a randomized-withdrawal study design.

Original language	English
Pages (from-to)	647
Number of pages	657
Journal	Journal of the American Academy of Child and Adolescent Psychiatry
Volume	53
Issue number	6
Early online date	3 Mar 2014
DOIs	https://doi.org/10.1016/j.jaac.2014.01.017
Publication status	Published - 2014

Access to Document

10.1016/j.jaac.2014.01.017Licence: CC BY-NC-ND

Publisher final version
Copyright © 2014 American Academy of Child and Adolescent Psychiatry. This article is published under the terms of the Creative Commons Attribution-NonCommercial-No Derivatives License (CC BY NC ND). For non-commercial purposes you may copy and distribute the article, use portions or extracts from the article in other works, and text or data mine the article, provided you do not alter or modify the article without permission from Elsevier. You may also create adaptations of the article for your own personal use only, but not distribute these to others. You must give appropriate credit to the original work, together with a link to the formal publication through the relevant DOI, and a link to the Creative Commons user license above. If changes are permitted, you must indicate if any changes are made but not in any way that suggests the licensor endorses you or your use of the work.
Final published version, 549 KBLicence: CC BY-NC-ND

Cite this

Coghill, D. R., Banaschewski, T., Lecendreux, M., Johnson, M., Zuddas, A., Anderson, C. S., Civil, R., Dauphin, M., Higgins, N., Lyne, A., Gasior, M., & Squires, L. A. (2014). Maintenance of efficacy of lisdexamfetamine dimesylate in children and adolescents with attention-deficit/hyperactivity disorder: randomized-withdrawal study design. Journal of the American Academy of Child and Adolescent Psychiatry, 53(6), 647. https://doi.org/10.1016/j.jaac.2014.01.017

@article{6a0907635b484c1f924014c37584e350,

title = "Maintenance of efficacy of lisdexamfetamine dimesylate in children and adolescents with attention-deficit/hyperactivity disorder: randomized-withdrawal study design",

abstract = "In this phase 3 extension study, the long-term maintenance of efficacy of lisdexamfetamine dimesylate (LDX) in children and adolescents with attention-deficit/hyperactivity disorder (ADHD) was evaluated using a randomized-withdrawal study design.",

author = "Coghill, \{David R.\} and Tobias Banaschewski and Michel Lecendreux and Mats Johnson and Alessandro Zuddas and Anderson, \{Colleen S.\} and Richard Civil and Matthew Dauphin and Nicholas Higgins and Andrew Lyne and Maria Gasior and Squires, \{Liza A.\}",

year = "2014",

doi = "10.1016/j.jaac.2014.01.017",

language = "English",

volume = "53",

pages = "647",

journal = "Journal of the American Academy of Child and Adolescent Psychiatry",

issn = "0890-8567",

publisher = "Elsevier",

number = "6",

}

Coghill, DR, Banaschewski, T, Lecendreux, M, Johnson, M, Zuddas, A, Anderson, CS, Civil, R, Dauphin, M, Higgins, N, Lyne, A, Gasior, M & Squires, LA 2014, 'Maintenance of efficacy of lisdexamfetamine dimesylate in children and adolescents with attention-deficit/hyperactivity disorder: randomized-withdrawal study design', Journal of the American Academy of Child and Adolescent Psychiatry, vol. 53, no. 6, pp. 647. https://doi.org/10.1016/j.jaac.2014.01.017

Maintenance of efficacy of lisdexamfetamine dimesylate in children and adolescents with attention-deficit/hyperactivity disorder: randomized-withdrawal study design. / Coghill, David R. (Lead / Corresponding author); Banaschewski, Tobias; Lecendreux, Michel et al.
In: Journal of the American Academy of Child and Adolescent Psychiatry, Vol. 53, No. 6, 2014, p. 647.

Research output: Contribution to journal › Article › peer-review

TY - JOUR

T1 - Maintenance of efficacy of lisdexamfetamine dimesylate in children and adolescents with attention-deficit/hyperactivity disorder

T2 - randomized-withdrawal study design

AU - Coghill, David R.

AU - Banaschewski, Tobias

AU - Lecendreux, Michel

AU - Johnson, Mats

AU - Zuddas, Alessandro

AU - Anderson, Colleen S.

AU - Civil, Richard

AU - Dauphin, Matthew

AU - Higgins, Nicholas

AU - Lyne, Andrew

AU - Gasior, Maria

AU - Squires, Liza A.

PY - 2014

Y1 - 2014

N2 - In this phase 3 extension study, the long-term maintenance of efficacy of lisdexamfetamine dimesylate (LDX) in children and adolescents with attention-deficit/hyperactivity disorder (ADHD) was evaluated using a randomized-withdrawal study design.

AB - In this phase 3 extension study, the long-term maintenance of efficacy of lisdexamfetamine dimesylate (LDX) in children and adolescents with attention-deficit/hyperactivity disorder (ADHD) was evaluated using a randomized-withdrawal study design.

U2 - 10.1016/j.jaac.2014.01.017

DO - 10.1016/j.jaac.2014.01.017

M3 - Article

C2 - 24839883

SN - 0890-8567

VL - 53

SP - 647

JO - Journal of the American Academy of Child and Adolescent Psychiatry

JF - Journal of the American Academy of Child and Adolescent Psychiatry

IS - 6

ER -

Coghill DR, Banaschewski T, Lecendreux M, Johnson M, Zuddas A, Anderson CS et al. Maintenance of efficacy of lisdexamfetamine dimesylate in children and adolescents with attention-deficit/hyperactivity disorder: randomized-withdrawal study design. Journal of the American Academy of Child and Adolescent Psychiatry. 2014;53(6):647. Epub 2014 Mar 3. doi: 10.1016/j.jaac.2014.01.017

Maintenance of efficacy of lisdexamfetamine dimesylate in children and adolescents with attention-deficit/hyperactivity disorder: randomized-withdrawal study design

Abstract

Access to Document

Fingerprint

Cite this